Safety and efficacy of SHR-1316 combined with chemotherapy and sequential chest radiotherapy as first-line therapy for extensive-stage small cell lung cancer (ES-SCLC): The results from a phase II single-arm trial.

Authors

null

Dawei Chen

Shandong Cancer Hospital Affiliated to Shandong University, Jinan, China

Dawei Chen , Bing Zou , Xiangjiao Meng , Wei Huang , Qian Shao , Xiaoyong Tang , Jun Guo , Xudong Hu , Yan Zhang , Lei Fu , Yuan Jiajia , Jinming Yu , Linlin Wang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

Track

Lung Cancer

Sub Track

Small Cell Lung Cancer

Clinical Trial Registration Number

NCT04562337

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 8563)

DOI

10.1200/JCO.2022.40.16_suppl.8563

Abstract #

8563

Poster Bd #

190

Abstract Disclosures